Researchers Found Few Symptom Differences Between Schizophrenia Patients Who Did and Didn't Use Cannabis
Among 757 first-episode schizophrenia cases, those who used cannabis showed largely the same symptoms and family history as those who did not.
Quick Facts
What This Study Found
The study examined 757 people experiencing their first episode of schizophrenia, of whom 182 (24%) had used cannabis in the year before their first presentation.
After controlling for age, sex, and ethnicity, researchers found no statistically significant differences in any measured symptom between cannabis users and non-users. This included bizarre behavior, thought disorder, negative symptoms, delusions of reference, paranoid delusions, and first-rank symptoms.
There were two borderline findings among cannabis users: a non-significant trend toward better insight and fewer abusive or accusatory hallucinations. Family history of schizophrenia did not differ between the two groups.
Key Numbers
757 first-episode schizophrenia cases examined. 182 (24%) had used cannabis in the prior year. Loss of insight: OR 0.65 (p=0.055). Fewer abusive hallucinations: OR 0.65 (p=0.049, borderline).
How They Did This
Researchers used the Camberwell case register containing 757 cases of first-onset schizophrenia. They completed the OPCRIT checklist on all patients and used chi-square tests followed by logistic regression to compare symptoms between cannabis users and non-users, controlling for age, sex, and ethnicity.
Why This Research Matters
There has been long-standing debate about whether cannabis causes a distinct form of psychosis that differs from "typical" schizophrenia. This study's finding of minimal symptom differences argues against a separate "cannabis psychosis" and suggests that cannabis-associated schizophrenia is clinically indistinguishable from other forms.
The Bigger Picture
This study contributed to the scientific conversation about whether cannabis triggers a unique type of psychosis or acts as a general risk factor for schizophrenia. The lack of meaningful symptom differences supports the idea that cannabis may increase risk for the same illness rather than creating a distinct diagnostic category.
What This Study Doesn't Tell Us
Cannabis use was self-reported and measured only in the year before first presentation, which may not capture lifetime use patterns. The study was cross-sectional, so it could not determine whether cannabis played a causal role. Symptom assessment occurred at first presentation only.
Questions This Raises
- ?If cannabis-associated schizophrenia looks the same as other schizophrenia, does cannabis simply accelerate onset in people already at risk?
- ?Would longer-term follow-up reveal different symptom trajectories?
Trust & Context
- Key Stat:
- 757 first-episode schizophrenia cases showed no significant symptom differences by cannabis use
- Evidence Grade:
- This is a cross-sectional case register study with a substantial sample size, but it cannot establish causal relationships and relied on self-reported cannabis use.
- Study Age:
- Published in 2007. Subsequent research has continued to debate the "cannabis psychosis" concept, with most evidence suggesting cannabis is a risk factor for schizophrenia rather than a cause of a distinct condition.
- Original Title:
- A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
- Published In:
- Schizophrenia research, 93(1-3), 203-10 (2007)
- Authors:
- Boydell, J, Dean, K, Dutta, R, Giouroukou, E, Fearon, P, Murray, R
- Database ID:
- RTHC-00265
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What is "cannabis psychosis"?
Cannabis psychosis is a debated concept suggesting that cannabis use can cause a distinct form of psychotic illness with different symptoms than typical schizophrenia. This study found little evidence to support that distinction.
Does this mean cannabis doesn't cause psychosis?
Not necessarily. The study examined whether cannabis-associated schizophrenia looks different, not whether cannabis contributes to developing schizophrenia. Other research has found associations between cannabis use and increased psychosis risk.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- thc-and-antipsychotics-complicated-relationship
Cite This Study
https://rethinkthc.com/research/RTHC-00265APA
Boydell, J; Dean, K; Dutta, R; Giouroukou, E; Fearon, P; Murray, R. (2007). A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.. Schizophrenia research, 93(1-3), 203-10.
MLA
Boydell, J, et al. "A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.." Schizophrenia research, 2007.
RethinkTHC
RethinkTHC Research Database. "A comparison of symptoms and family history in schizophrenia..." RTHC-00265. Retrieved from https://rethinkthc.com/research/boydell-2007-a-comparison-of-symptoms
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.